Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Ischemic Stroke: early-phase trial registry
30 of 67 indexed Ischemic Stroke trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #208 of 28,707 conditions by registered trial count.
67 US clinical trials · 30 currently recruiting · #208 of 28,707 conditions by registered trial count
Ischemic Stroke: 67 US clinical trials tracked, 30 recruiting.
Ischemic Stroke is the subject of 67 registered US clinical trials on ClinicalTrials.gov, 30 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 19 in Phase 1-2 (earlier-stage). The most active sponsor is Johns Hopkins University, running 4 of these trials.
Enrollment posture brief
Registry condition ischemic-stroke
OPEN 30 | RECR 45% | LATE 3 | EARLY 19 | RANK #208 | SPON 4
Volume-matched condition peers
Nearest open-share peer: Food Insecurity (45% recruiting · 38 trials)
Ischemic Stroke lists 30 open slots (45% of 67 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Ischemic Stroke on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Ischemic Stroke is recruiting above its size-band peers.
30 of 67 indexed trials (44.8%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Ischemic Stroke trials is spread across many organizations.
Johns Hopkins University accounts for 4 of 67 trials (6%). 52 distinct sponsors appear on at least one study for this condition label.
-
Typical Ischemic Stroke enrolment sits around 83 participants.
Median target enrolment is 83 among the 67 trials that report a genuine target (sentinel values excluded). 35 of those (52.2%) plan for fewer than 100 participants.
-
Ischemic Stroke research is mostly interventional.
48 interventional and 19 observational studies make up this index (71.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
67 total, page 2 of 2
Hemodynamic Effects on Cerebral Autoregulation in Acute Stroke
Henry Ford Health System
NCT02056821
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Acorda Therapeutics
NCT01605825
Functional Magnetic Resonance Imaging (fMRI) and Robot-Assisted Practice of Activities of Daily Living
Medical College of Wisconsin
NCT00878085
The Capillary Index Score Trial
Firas Al-Ali
NCT02618031
Occult Paroxysmal Atrial Fibrillation in Non-Cryptogenic Ischemic Stroke
Northwell Health
NCT02232022
The PERFusion Use in Stroke Evaluation Study
California Pacific Medical Center Research Institute
NCT01387113
Stroke and CPAP Outcome Study 3
University of Washington
NCT06029959
Mayo Acute Stroke Trial for Enhancing Recovery
Mayo Clinic
NCT00805792
Safety/Feasibility of Autologous Mononuclear Bone Marrow Cells in Stroke Patients
The University of Texas Health Science Center, Houston
NCT00859014
REcurrent Stroke Prevention Through Personalized Education by Clinical Trainers (RESPPECT Trial)
Washington Regional Medical Center
NCT03861494
Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy Pilot Trial
ProMedica Health System
NCT05172934
Dietary Nitrate Supplements and Ischemic Stroke Recovery
Wake Forest University Health Sciences
NCT02838901
Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST)
National Institute of Neurological Disorders and Stroke (NINDS)
NCT00061373
A Study to Evaluate the Effect of Diltiazem on the Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects
Bristol-Myers Squibb
NCT02922452
Assessing the Safety and Effectiveness of a Neurological Thrombectomy Medical Device for Acute Ischemic Stroke
Jacobs institute
NCT05074186
IV vs. IA tPA (Activase) in Acute Ischemic Stroke With CTA Evidence of Major Vessel Occlusion
University of North Carolina, Chapel Hill
NCT00624000
Hyperbaric Oxygen and Manipulative Therapies to Regain Function Post Stroke
Abington Memorial Hospital
NCT03352232
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 10 |
| Phase 2 | 9 |
| Phase 4 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Ischemic Stroke records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Ischemic Stroke trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Ischemic Stroke page
67 registered trials, 30 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 30 Ischemic Stroke trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Johns Hopkins University sponsors the most Ischemic Stroke trials on record, review their full trial history before evaluating a specific study. See Johns Hopkins University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Ischemic Stroke condition card totals 67 registered trials; most-linked intervention Aspirin; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.